MP52-19 COMPARISON OF IN-PERSON FPMRS-DIRECTED PELVIC FLOOR THERAPY PROGRAM VERSUS UNSUPERVISED PELVIC FLOOR EXERCISES FOLLOWING PROSTATECTOMY

Abstract

You have accessJournal of UrologyCME1 May 2022MP52-19 COMPARISON OF IN-PERSON FPMRS-DIRECTED PELVIC FLOOR THERAPY PROGRAM VERSUS UNSUPERVISED PELVIC FLOOR EXERCISES FOLLOWING PROSTATECTOMY Jacques Farhi, Anthony DeNovio, David Barquin, and David Rapp Jacques FarhiJacques Farhi More articles by this author , Anthony DeNovioAnthony DeNovio More articles by this author , David BarquinDavid Barquin More articles by this author , and David RappDavid Rapp More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002627.19AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Post-prostatectomy incontinence is common and associated with a high degree of patient distress. The UVA prostatectomy functional outcomes program (PFOP) was developed to comprehensively assess and optimize continence outcomes following robotic-assisted laparoscopic prostatectomy (RALP). Enrolled PFOP patients complete specialized in-person pelvic floor muscle training with a FPMRS specialist (DR), performed at baseline, 3-months, 6-months, and 12-months following surgery and supplemented by a home exercise program. This study compared continence outcomes in PFOP patients versus those receiving standard unsupervised home pelvic floor exercise therapy (UPFE) as directed by their urologic surgeon. METHODS: We performed a retrospective review of patients receiving PFMT versus UPFE with minimum 6-month follow-up. Incontinence and quality of life outcomes in all patients are prospectively assessed using the validated ICIQ-MLUTS and IIQ-7 questionnaires, in addition to items assessing daily pad use and satisfaction. Primary study outcomes included ICIQ-MLUTS SUI domain score and SUI cure (ICIQ SUI domain score = 0). RESULTS: Analysis included a total of 18 and 20 men with minimum 6-month follow-up receiving PFOP versus UPFE, respectively. No difference in patient age (62 vs 64 years), EBL (226 vs 182 ml), proportion of patients undergoing adjuvant radiotherapy (11% vs 10%), lymph node dissection (90% vs 85%), or baseline ICIQ SUI domain score (0.11 vs 0.05) was seen in comparison of PFOP versus UPFE cohorts (p=NS, all comparisons). Mean ICIQ-MLUTS SUI domain items scores across all time points are shown in Figure 1. At 6-month follow-up, men enrolled in PFOP demonstrated significantly improved SUI domain scores when compared to controls (PFOP 0.83 (SD 1.10); UPFE 1.8 (SD 1.47))(p<0.05). Similarly, a higher proportion of PFOP patients reported SUI cure (PFOP 50%; UPFE 25%)(p=0.10). Similar pad per day quantity was reported across the cohorts (PFOP 0.89 (SD 1.02); UPFE 1.0 (SD 1.38))(p=NS). CONCLUSIONS: In-person, FMPRS-directed PFMT is associated with improved SUI outcomes following RALP at 6-month follow-up. Further follow-up is ongoing to comprehensively assess outcomes through 1-year follow-up. Source of Funding: None © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e894 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Jacques Farhi More articles by this author Anthony DeNovio More articles by this author David Barquin More articles by this author David Rapp More articles by this author Expand All Advertisement PDF DownloadLoading ...